Market Intel

7 articles this week

Morning SPAC News Roundup: November 10, 2026

A reading of fresh CPI inflation figures is on the docket followed by a full day of comments by Fed officials. Futures are hopeful on the Dow side for these events, but the Nasdaq has continued to sag as it is down about -9. More

Nicholas Alan Clayton·Nov 10

Globa Terra (GTERA) to Combine with Nature’s Ledger in $324M Deal

Globa Terra (NASDAQ:GTERA) has entered into a definitive agreement to combine with sustainability firm Nature’s Ledger at a $323.8 million pre-money equity value. Nature's Ledger places real world ecological assets on the blockchain to allow investors to trade carbon credits based on their preservation or improvement. More

Nicholas Alan Clayton·Nov 9

SPAC IPO Terms Tracker: November 6, 2026

Terms Tracker for the Week Ending November 6, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. There were no IPOs priced this week, so the November monthly IPO count starts at zero, but deal announcements did the heavy lifting with five business combinations announced. More

Kristi Marvin·Nov 7

New SPACs: Churchill Capital XIV (CXIVU), Kartoon Studios (KACQ.U) File for IPOs

Churchill Capital Corp. XIV Churchill XIV has filed for a $300 million SPAC that would give the high-profile team a third vehicle out searching for a deal. The new SPAC is offering investors 1/10 warrants in its units, which is the same structure the team has gone with for the last three SPACs it has filed and IPO'd over the past year. More

Nicholas Alan Clayton·Nov 6

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. More

Nicholas Alan Clayton·Nov 6

BHAV I (BHAV) to Combine with Nemi Corp. in $400M Deal

BHAV I (NASDAQ:BHAV) has entered into a definitive agreement to combine with automated manufacturing firm Nemi Corp. at a pre-money equity value of $400 million. India-based Nemi is developing software and hardware for autonomous manufacturing that it plans to provide as a service to enterprise clients. More

Nicholas Alan Clayton·Nov 5

GP-Act III (GPAT) to Combine with Dronamics Group in $497M Deal

GP-Act III (NASDAQ:GPAT) has entered into a definitive agreement to combine with cargo drone maker Dronamics at a pro forma enterprise value of $497 million. Dronamics is developing fixed-wing cargo drones for logistics services in both commercial and defense domains. More

Nicholas Alan Clayton·Nov 4

New SPAC: UCSB Acquisition Corp. (UCSBU) Files for $60M IPO

UCSB has filed for a $60 million SPAC with an Asia-based team focused on target opportunities from that corner of the world. The new SPAC is offering investors one right to a 1/4 share in each unit and a trust that is to be overfunded to 100. More

Nicholas Alan Clayton·Nov 3

Morning SPAC News Roundup: November 3, 2026

Election day is upon us and it appears that both SPACs and de-SPACs lined up their business for just before the polls rather than during or after. More

Nicholas Alan Clayton·Nov 3

NorthStrive Acquisition Corp. I (NSAI) to Combine with Nuclea Energy in $350M Deal

NorthStrive I (NASDAQ:NSAI) has entered into a definitive agreement to combine with nuclear technology firm Nuclea Energy at an enterprise value of $350 million. Mississauga, Canada-based Nuclea is developing molten salt nuclear reactor designs that would be modular and scalable from 3. More

Nicholas Alan Clayton·Nov 2